TegoScience Inc. (KOSDAQ:191420)
South Korea · Delayed Price · Currency is KRW 14,200
0.00 (0.00%)
At close: Feb 19, 2026
TegoScience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 6,154 | 6,759 | 7,772 | 7,678 | 8,300 | 8,789 |
Other Revenue | -0 | -0 | - | -0 | -0 | 0 |
| 6,154 | 6,759 | 7,772 | 7,678 | 8,300 | 8,789 | |
Revenue Growth (YoY) | -11.15% | -13.04% | 1.23% | -7.49% | -5.57% | 38.50% |
Cost of Revenue | 1,931 | 1,998 | 2,496 | 2,078 | 1,936 | 2,198 |
Gross Profit | 4,223 | 4,761 | 5,277 | 5,600 | 6,364 | 6,592 |
Selling, General & Admin | 3,075 | 3,392 | 3,584 | 3,554 | 3,802 | 3,010 |
Research & Development | 3,801 | 2,663 | 2,576 | 1,608 | 2,328 | 1,852 |
Amortization of Goodwill & Intangibles | 28.88 | 27.69 | 27.78 | 31.93 | 31.83 | 28.33 |
Other Operating Expenses | 58.12 | 69.13 | 62.85 | 62 | 58.23 | 59.87 |
Operating Expenses | 8,002 | 7,367 | 6,461 | 5,370 | 6,462 | 5,075 |
Operating Income | -3,779 | -2,606 | -1,185 | 229.63 | -98.01 | 1,517 |
Interest Expense | -752.31 | -89.77 | -62.39 | -35.48 | -16.53 | -9.41 |
Interest & Investment Income | 1,099 | 895.97 | 813.49 | 572.17 | 250.31 | 272.98 |
Currency Exchange Gain (Loss) | 79.1 | 23.88 | -51.51 | -0.46 | 0.01 | -0.36 |
Other Non Operating Income (Expenses) | 127.49 | 469.55 | 179.12 | 15.18 | 15.48 | -7.78 |
EBT Excluding Unusual Items | -3,225 | -1,307 | -306.01 | 781.04 | 151.26 | 1,772 |
Gain (Loss) on Sale of Investments | 4,345 | 4,145 | -1,115 | -579.44 | -85.04 | -1,144 |
Gain (Loss) on Sale of Assets | -4,807 | -0 | -0 | -0 | - | 1,426 |
Asset Writedown | - | - | -1,142 | - | - | - |
Pretax Income | -3,688 | 2,839 | -2,563 | 201.59 | 66.21 | 2,054 |
Income Tax Expense | -419.76 | -477.5 | -219.74 | -54.41 | 18.67 | 244.16 |
Earnings From Continuing Operations | -3,268 | 3,316 | -2,343 | 256.01 | 47.55 | 1,810 |
Minority Interest in Earnings | 19.69 | 33.48 | 20.54 | 8.5 | 91.71 | 20.92 |
Net Income | -3,249 | 3,350 | -2,323 | 264.51 | 139.26 | 1,831 |
Net Income to Common | -3,249 | 3,350 | -2,323 | 264.51 | 139.26 | 1,831 |
Net Income Growth | - | - | - | 89.95% | -92.40% | 114.03% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Change (YoY) | -0.09% | - | -0.02% | -0.43% | -0.16% | -0.30% |
EPS (Basic) | -405.91 | 418.36 | -290.08 | 33.03 | 17.31 | 227.30 |
EPS (Diluted) | -406.28 | 418.00 | -290.08 | 33.00 | 17.00 | 227.00 |
EPS Growth | - | - | - | 94.12% | -92.51% | 114.39% |
Free Cash Flow | -2,911 | -1,196 | -830.74 | 1,025 | 441.05 | 1,214 |
Free Cash Flow Per Share | -363.78 | -149.40 | -103.76 | 127.97 | 54.84 | 150.74 |
Gross Margin | 68.62% | 70.44% | 67.89% | 72.93% | 76.68% | 75.00% |
Operating Margin | -61.40% | -38.56% | -15.24% | 2.99% | -1.18% | 17.26% |
Profit Margin | -52.78% | 49.56% | -29.88% | 3.45% | 1.68% | 20.84% |
Free Cash Flow Margin | -47.30% | -17.70% | -10.69% | 13.35% | 5.31% | 13.82% |
EBITDA | -3,229 | -2,067 | -637.63 | 811.02 | 490.7 | 2,114 |
EBITDA Margin | -52.47% | -30.58% | -8.20% | 10.56% | 5.91% | 24.05% |
D&A For EBITDA | 549.56 | 539.53 | 547.11 | 581.39 | 588.71 | 597.22 |
EBIT | -3,779 | -2,606 | -1,185 | 229.63 | -98.01 | 1,517 |
EBIT Margin | -61.40% | -38.56% | -15.24% | 2.99% | -1.18% | 17.26% |
Effective Tax Rate | - | - | - | - | 28.19% | 11.88% |
Advertising Expenses | - | 363.39 | 450.76 | 521.39 | 873.43 | 136.22 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.